Skip to content

Clinical trials

Completed Central Nervous System Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Status: Completed Country / region: Canada Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20102
20121
20133
20142
20151
20163
20171
20181
20192
20204
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
University of British Columbia3
Eli Lilly and Company2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
AbbVie (prior sponsor, Abbott)1
Centre hospitalier de l'Université de Montréal (CHUM)1
GlaxoSmithKline1
Inmune Bio, Inc.1
Microvention-Terumo, Inc.1
MyndTec Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases23
Brain Diseases19
Nervous System Diseases16
Cerebrovascular Disorders8
Neurodegenerative Diseases7
Brain Ischemia6
Cardiovascular Diseases6
Movement Disorders6
Stroke6
Vascular Diseases6

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.